MID-VOLUME · HOSP-HEAVY
indapamide Side Effects
indapamide (also sold as Lozol) sits MID-VOLUME #255 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 47.0% mention hospitalization (8,087 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 17,199
- FAERS reports
FDA Adverse Event Reporting System extract for indapamide. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
indapamide: 47.0% mention hospitalization (8,087 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #255 of 524 by FAERS report count.
Mid-book FAERS page for indapamide (Lozol) (17,199 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
HYPONATRAEMIA leads 1,286 of 17,199 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (4,518 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,091 reports, 6.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 194 |
| ACUTE KIDNEY INJURY | 86 |
| DIARRHOEA | 70 |
| CARDIAC ARREST | 61 |
| PNEUMONIA | 61 |
| VOMITING | 52 |
| DYSPNOEA | 49 |
| LACTIC ACIDOSIS | 48 |
| FALL | 45 |
| RENAL FAILURE | 45 |
| ANAEMIA | 42 |
| SEPSIS | 41 |
| FATIGUE | 39 |
| MALAISE | 38 |
| MYOCARDIAL INFARCTION | 38 |
| NAUSEA | 37 |
| ABDOMINAL PAIN | 35 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 35 |
| HYPERTENSION | 35 |
| INTERSTITIAL LUNG DISEASE | 35 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (8,087, 47.0% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| HYPONATRAEMIA | 1,110 |
| ACUTE KIDNEY INJURY | 671 |
| HYPOKALAEMIA | 568 |
| DYSPNOEA | 498 |
| VOMITING | 492 |
| FALL | 477 |
| DRUG INTERACTION | 456 |
| DIARRHOEA | 437 |
| NAUSEA | 426 |
| CONFUSIONAL STATE | 424 |
| HYPOTENSION | 417 |
| DIZZINESS | 403 |
| MALAISE | 379 |
| ASTHENIA | 365 |
| FATIGUE | 332 |
| PNEUMONIA | 313 |
| PYREXIA | 303 |
| ABDOMINAL PAIN | 295 |
| DEHYDRATION | 291 |
| ATRIAL FIBRILLATION | 287 |
How to read indapamide FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 17,199 voluntary reports linked to indapamide (Lozol), 2004-2025. Death is listed on 1,091 (6.3%). Hospitalization appears on 8,087 (47.0%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 47.0% mention hospitalization (8,087 reports).
Read with indapamide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 17,186 FAERS cases (Δ 13 lighter vs indapamide); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 17,328 FAERS cases (Δ 129 heavier vs indapamide); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 17,378 FAERS cases (Δ 179 heavier vs indapamide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 17,512 FAERS cases (Δ 313 heavier vs indapamide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.8 pp vs indapamide's DEATH-HEAVY): CASELOAD · HOSP-MID.
indapamide stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.